ATMP Supply Chain: Navigating the Challenges and Exploring the Vein-to-Vein Strategy

Lieve De Wolf is a highly accomplished and passionate ATMP (Advanced Therapy Medicinal Products) supply chain expert, armed with a degree in industrial pharmacy from 2014. With extensive experience as the ATMP core team leader within the QbD Group, Lieve is at the forefront of driving innovation and excellence in the field.

Presently, Lieve holds a pivotal role in the EMEA region, where she oversees surveillance audits and the qualification of sites for the commercial launch of CAR-T therapies. Through her expertise, Lieve is making remarkable strides in ensuring the highest standards of quality and compliance are met, ultimately contributing to the successful implementation of ATMP supply chains.